Dr. John Campbell

New covid vaccine for UK

Dr. John Campbell

Show Notes

Bivalent new vaccine, Moderna press releaseUploaded 19-08-22https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-Omicron-Containing-Bivalent-Booster-Candidate-mRNA-1273.214-Demonstrates-Superior-Antibody-Response-Against-Omicron/default.aspxOmicron-containing bivalent COVID booster candidate, mRNA-1273.214(original mRNA-1273 vaccine),Superior neutralizing antibody responsein baseline seronegative participants. increased neutralizing geometric mean titers (GMT) against Omicron approximately 8-fold above baseline levels. mRNA-1273.214 50 μg booster dose, well-tolerated in the 437 study participantsThe safety and reactogenicity profile of the mRNA-1273.214 50 μg booster dose was similar to that of mRNA-1273 50 μgBA.1SARS-CoV-2 variants of concern and variants under investigation in England Technical briefing 44 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1093275/covid-technical-briefing-44-22-july-2022.pdfBA.2 3.4% BA.4 17.2% BA.5 78.7%Other 0.7%US variantshttps://covid.cdc.gov/covid-data-tracker/#variant-proportionsBA.5 88.8%BA.4 5.3%BA.4.6 5.1%BA.2.12.1 0.8%BA.2 0%BA.1s 0%Delta 0%Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canadahttps://jamanetwork.com/journals/jamanetworkopen/fullarticle/2793551Population-based cohort study of 297 individuals in Ontario, Canada,with myocarditis or pericarditis following COVID-19 vaccination,found higher rates of myocarditis or pericarditis associated with receipt of mRNA-1273 compared with BNT162b2 as a second dose, particularly among male individuals aged 18 to 24 years. The results suggest that there may be product-specific differences in rates of myocarditis or pericarditis after receiving mRNA vaccinesFirst bivalent COVID-19 booster vaccine approved by UK medicines regulatorhttps://www.gov.uk/government/news/first-bivalent-covid-19-booster-vaccine-approved-by-uk-medicines-regulatorModerna bivalent approved for adult booster doses by MHRASpikevax bivalent Original/Omicron25 micrograms targets the original virus strain25 micrograms targets OmicronOmicron (BA.1) and the original 2020 strain(was also found to generate a good immune response against BA.4 and BA.5)Safety monitoringside effects observed were the same as those seen for the original Moderna booster dose,and were typically mild and self-resolving, and no serious safety concerns were identified.Global covid deathshttps://www.worldometers.info/coronavirus/6,466,947Evidence cited by HMRAhttps://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2822%2900320-6/fulltextBased on official reported COVID-19 deaths, we estimated that vaccinations prevented 14·4 million deaths from COVID-19 in 185 countries,between Dec 8, 2020, and Dec 8, 2021. 19·8 million when we used excess deaths as an estimateJoint Committee on Vaccination and Immunisation (JCVI) updated statement on the COVID-19 vaccination programme for autumn 2022For autumn 2022https://www.gov.uk/government/publications/jcvi-updated-statement-on-the-covid-19-vaccination-programme-for-autumn-2022/joint-committee-on-vaccination-and-immunisation-jcvi-updated-statement-on-the-covid-19-vaccination-programme-for-autumn-2022JCVI advisesthe following groups should be offered a COVID-19 booster vaccine:residents in a care home for older adults and staff working in care homes for older adultsfrontline health and social care workersall adults aged 50 years and overpersons aged 5 to 49 years in a clinical risk group persons aged 5 to 49 years who are household contacts of people with immunosuppressionpersons aged 16 to 49 years who are carers Time to collect PROSPECT Learn more about your ad choices. Visit megaphone.fm/adchoices

More from Dr. John Campbell

Oct 24, 2026

Dr. David Grimes, consultant physician gives amazing information on the importance of immunity and vitamin D. Buy his inexpensive latest book here. https://yorkbookshop.com/health-and-personal-development/307-vitamin-d-deficiency-and-covid-19-its-central-role-in-a-world-pandemic.html Uploaded 15-01-24Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Oct 24, 2026

UK infections highest ever in the pandemic so far.Uploaded 23-03-22New ZealandStop vaccine passes and vaccine mandates for some of the workforce, early AprilStopping gathering limits in outdoor settingsRequirements to use the Covid-19 tracer app when entering businesses.Michael Plank, Te Pūnaha Matatini and University of CanterburyVaccines are still hugely effective at preventing severe illness, but less effective at stopping people catching and spreading the virusAt the same time, we now have increasing levels of infection-acquired immunity in the population. This means that allowing unvaccinated people into places like cafes and bars doesn’t substantially alter the risk of catching Covid thereAt least as many people will be infected on the way down the mountain as on the way up, and pressure on our healthcare system is likely to remain high. Keeping mask rules is crucial to limit transmissionChinaCases, + 4,770HTTPS://WWW.THEGUARDIAN.COM/WORLD/2022/MAR/22/CHINA-LOCKS-DOWN-CITY-OF-9-MILLION-AND-REPORTS-4000-CASES-AS-OMICRON-TESTS-ZERO-COVID-STRATEGYCity of Shenyang, (9 million people)Cases, + 47All housing compounds under ‘closed management’Local lockdowns, mass testing and citywide closuresDozens of officials have been punished or sacked for virus control failuresOnly around half of Chinese aged over 80 have been double-vaccinatedZoe datahttps://covid.joinzoe.com/dataUK official datahttps://coronavirus.data.gov.ukONSHTTPS://WWW.ONS.GOV.UK/PEOPLEPOPULATIONANDCOMMUNITY/HEALTHANDSOCIALCARE/CONDITIONSANDDISEASES/ARTICLES/CORONAVIRUSCOVID19/LATESTINSIGHTSPrevalence4.87% in England (1 in 20 people) 4.13% in Wales (1 in 25 people) 7.12% in Northern Ireland (1 in 14 people) 7.15% in Scotland (1 in 14 people) Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Oct 24, 2026

Data is excellent, as far as it goes ....Uploaded 13-04-22African been planting, original video, https://www.youtube.com/watch?v=dKY1WllV4YACheck out the Africa medical channel for more great content, https://www.youtube.com/channel/UCzsLklGgOttU3Se-WGLp7owPrevalence, week ending 2 April 2022https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights7.60% in England (1 in 13 people) 7.59% in Wales (1 in 13 people) 6.21% in Northern Ireland (1 in 16 people) 7.54% in Scotland (1 in 13 people)People were more likely to test positive in the two weeks up to 26 March 2022 if they: had not previously been infected with COVID-19 travelled abroad in the last 28 days reported being of White ethnicity worked outside the home 2, 3 or 4 days a week had not been living in a multigenerational household were male were not impacted by a disability had not had contact with hospitals lived in less deprived areasReinfections were 10 times higher in the Omicron variant period than in the Delta variant periodBetween 2 July 2020 and 20 March 2022, people were more likely to be reinfected if they: were unvaccinated had a "milder" primary infection with a lower viral load were younger lived in more deprived areas Self-reported long COVIDAs of 5 March 20221.7 million people, (2.7% of the population)69% symptoms at least 12 weeks45% at least one yearLong symptomsFatigue, 51%Shortness of breath, 34%Loss of smell, 28%Muscle ache, 24%Adversely affected the day-to-day activities of 67%Long covid, more common in Aged 35 to 49 yearsFemalesMore deprived areasWorking in social care, teaching and education, or health careAnother activity-limiting health condition or disability.  1.0% primary school age, met all the criteria for long COVID, at some point since March 20202.7% secondary school age, met all the criteria for long COVID at some point since March 2020Hospital admissionsAdmissions with covid and admissions for covid not differentiatedRisk of death in omicron times67% lower following an Omicron variant infection compared with the Delta variantNo evidence of a change in the risk of death following COVID-19 vaccination in young people 12 weeks after vaccination, aged 12 to 29 years. COVID-19 mortality rates lowest for those with three vaccinationsThe risk of death involving COVID-19 in England has been consistently lower for people who had a third vaccine dosePeople who had received a second vaccine,had a higher risk of death involving COVID-19 if their second vaccine dose was over six months agoAntibodiesInfected or vaccinatedAntibodies above a 179 nanograms per millilitre (ng/ml) threshold98.8% in England 98.8% in Wales 99.0% in Northern Ireland 98.9% in Scotland Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Oct 24, 2026

Presentation to the European Parliament

Oct 24, 2026

the medical people I interact with at the hospital are far more optimistic than I've seen them since this all began in April last year

See all episodes →